loader
Please Wait
Applying Filters...
menu
    • menu

    Approved Drug Products of Loxo Oncology Inc listed in the FDA Orange Book. Original Data : FDA Website

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Loxo Oncology Inc

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2PIRTOBRUTINIB

    02 8SELPERCATINIB

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    Brand Name : JAYPIRCA

    U.S.A
    Luxepack
    Not Confirmed
    arrow

    Brand Name : JAYPIRCA

    U.S.A
    Luxepack
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    PIRTOBRUTINIB

    Loxo Oncology Inc

    Dosage Form : TABLET; ORAL

    Proprietary Name : JAYPIRCA

    Dosage Strength : 50MG

    Approval Date : 2023-01-27

    Application Number : 216059

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : JAYPIRCA

    U.S.A
    Luxepack
    Not Confirmed
    arrow

    Brand Name : JAYPIRCA

    U.S.A
    Luxepack
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    PIRTOBRUTINIB

    Loxo Oncology Inc

    Dosage Form : TABLET; ORAL

    Proprietary Name : JAYPIRCA

    Dosage Strength : 100MG

    Approval Date : 2023-01-27

    Application Number : 216059

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Loxo Oncology Inc

    Dosage Form : CAPSULE; ORAL

    Proprietary Name : RETEVMO

    Dosage Strength : 40MG

    Approval Date : 2020-05-08

    Application Number : 213246

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Loxo Oncology Inc

    Dosage Form : CAPSULE; ORAL

    Proprietary Name : RETEVMO

    Dosage Strength : 80MG

    Approval Date : 2020-05-08

    Application Number : 213246

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Loxo Oncology Inc

    Dosage Form : TABLET; ORAL

    Proprietary Name : RETEVMO

    Dosage Strength : 40MG

    Approval Date : 2024-04-10

    Application Number : 218160

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Loxo Oncology Inc

    Dosage Form : TABLET; ORAL

    Proprietary Name : RETEVMO

    Dosage Strength : 80MG

    Approval Date : 2024-04-10

    Application Number : 218160

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Loxo Oncology Inc

    Dosage Form : TABLET; ORAL

    Proprietary Name : RETEVMO

    Dosage Strength : 120MG

    Approval Date : 2024-04-10

    Application Number : 218160

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Loxo Oncology Inc

    Dosage Form : TABLET; ORAL

    Proprietary Name : RETEVMO

    Dosage Strength : 160MG

    Approval Date : 2024-04-10

    Application Number : 218160

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow

    10

    Brand Name : RETEVMO

    U.S.A
    Luxepack
    Not Confirmed
    arrow